Even with the cheaper entry price, we're sitting this one out for now. Here are three reasons why there are better opportunities than TXG and a stock we'd rather own. Founded in 2012, 10x Genomics ...

Charles Schwab Investment Management Inc. lessened its stake in 10x Genomics, Inc. (NASDAQ:TXG – Free Report) by 17.2% in the ...

Scotiabank boosted their FY2026 EPS estimates for shares of Torex Gold Resources in a research report issued to clients and ...

Buy 10x Genomics with a 1-year target of $12.7, projecting 18% growth. Read here for more on TXG stock's biopharma potential ...

TXG) stock increased significantly by 33% over the... Compelling results return multiple high-grade intercepts at both Media Luna East and West (All amounts expressed in U.S. dollars unless ...

Serge Saxonov, the Chief Executive Officer of $TXG, sold 7,942 shares of the company on 02-28-2025 for an estimated $84,393. We received data on the trade from a ...

Here are three reasons why there are better opportunities than TXG and a stock we'd rather own. Founded in 2012, 10x Genomics (NASDAQ:TXG) develops single-cell and spatial genomics solutions ...

Get the full stock story straight from our expert analysts, it’s free. Even with the cheaper entry price, we're sitting this one out for now. Here are three reasons why there are better opportunities ...

Here are three reasons why there are better opportunities than TXG and a stock we'd rather own. Free cash flow isn't a prominently featured metric in company financials and earnings releases ...